M-4363-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The ENST00000387372.1(MT-TQ):n.38A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Mitomap GenBank:
𝑓 0.00090 ( AC: 55 )
Consequence
MT-TQ
ENST00000387372.1 non_coding_transcript_exon
ENST00000387372.1 non_coding_transcript_exon
Scores
Mitotip
Benign
Clinical Significance
Metabolic-syndrome-and-polycystic-ovary-syndrome-/-possibly-associated-w-DEAF-+-RP-+-dev-delay-/-hypertension-/-LHON
Conservation
PhyloP100: -0.938
Genes affected
MT-TQ (HGNC:7495): (mitochondrially encoded tRNA glutamine)
MT-TM (HGNC:7492): (mitochondrially encoded tRNA methionine)
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant M-4363-T-C is Benign according to our data. Variant chrM-4363-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 235017.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomadMitoHomoplasmic at 72
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRNQ | TRNQ.1 use as main transcript | n.38A>G | non_coding_transcript_exon_variant | 1/1 | ||||
TRNM | TRNM.1 use as main transcript | upstream_gene_variant | ||||||
TRNI | TRNI.1 use as main transcript | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MT-TQ | ENST00000387372.1 | n.38A>G | non_coding_transcript_exon_variant | 1/1 | ||||||
MT-TM | ENST00000387377.1 | upstream_gene_variant | ||||||||
MT-TI | ENST00000387365.1 | downstream_gene_variant |
Frequencies
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
Mitomap GenBank
AF:
AC:
55
Gnomad homoplasmic
AF:
AC:
72
AN:
56424
Gnomad heteroplasmic
AF:
AC:
2
AN:
56424
Alfa
AF:
Hom.:
Mitomap
Metabolic-syndrome-and-polycystic-ovary-syndrome-/-possibly-associated-w-DEAF-+-RP-+-dev-delay-/-hypertension-/-LHON
ClinVar
Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Dec 18, 2012 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. MT-TQ m.4363 T>C Given the data reviewed below, we classify this variant as a variant of uncertain significance. This variant has not been reported in association with cardiomyopathy. It has been reported in association with other mitochondrial phenotypes but it has also been seen in controls. Wong et al (2002) reported the variant as homoplasmic in a 7yo girl with retinitis pigmentosa, hearing loss, and failure to thrive. Zhu et al (2009) repoted a decrase in oxygen consumptionm rate in cell lines with this variant. Abu-Amero et al (2008) observed the variant in a patient with psudoexfoliation syndrome and considered the variant not pathobenic. The variant has been seen in a total of 8 out of 12,830 individuals studies. It was observed in 1 of 2704 individuals in mtDB, 2 of 3735 individuals in MitoWheel. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | Jan 04, 2023 | - - |
Juvenile myopathy, encephalopathy, lactic acidosis AND stroke Benign:1
Benign, criteria provided, single submitter | clinical testing | Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine | Jul 12, 2019 | The NC_012920.1:m.4363T>C variant in MT-TQ gene is interpreted to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes reported in the guidelines: BS1, BS4, BP4 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mitotip
Benign
Hmtvar
Pathogenic
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at